GP
DGX icon

Girard Partners’s Quest Diagnostics DGX Stock Holding History

Girard Partners’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$228K Sell
1,662
-870
-34% -$119K 0.02% 243
2024
Q1 		$337K Sell
2,532
-512
-17% -$66.4K 0.03% 219
2023
Q4 		$420K Sell
3,044
-2,133
-41% -$280K 0.04% 196
2023
Q3 		$631K Sell
5,177
-2,339
-31% -$312K 0.07% 160
2023
Q2 		$1.06M Sell
7,516
-13,034
-63% -$1.8M 0.11% 137
2023
Q1 		$2.91M Sell
20,550
-4,557
-18% -$652K 0.32% 73
2022
Q4 		$3.93M Sell
25,107
-594
-2% -$85.4K 0.45% 57
2022
Q3 		$3.15M Sell
25,701
-1,503
-6% -$198K 0.42% 61
2022
Q2 		$3.62M Sell
27,204
-1,888
-6% -$257K 0.46% 61
2022
Q1 		$3.98M Sell
29,092
-11,185
-28% -$1.56M 0.44% 62
2021
Q4 		$6.97M Sell
40,277
-727
-2% -$111K 0.76% 39
2021
Q3 		$5.96M Buy
41,004
+406
+1% +$59.4K 0.75% 36
2021
Q2 		$5.36M Buy
40,598
+1,702
+4% +$223K 0.69% 41
2021
Q1 		$4.99M Buy
38,896
+1,796
+5% +$221K 0.72% 43
2020
Q4 		$4.42M Buy
37,100
+1,435
+4% +$175K 0.68% 47
2020
Q3 		$4.08M Buy
35,665
+6,665
+23% +$787K 0.68% 45
2020
Q2 		$3.3M Sell
29,000
-672
-2% -$71.3K 0.6% 47
2020
Q1 		$2.38M Buy
29,672
+2,883
+11% +$298K 0.48% 61
2019
Q4 		$2.86M Buy
26,789
+793
+3% +$82.7K 0.47% 63
2019
Q3 		$2.78M Buy
25,996
+703
+3% +$72.2K 0.52% 62
2019
Q2 		$2.58M Buy
25,293
+880
+4% +$84.6K 0.45% 67
2019
Q1 		$2.19M Buy
24,413
+8,812
+56% +$764K 0.41% 71
2018
Q4 		$1.3M Buy
15,601
+2,211
+17% +$207K 0.27% 88
2018
Q3 		$1.44M Buy
13,390
+4,300
+47% +$472K 0.26% 94
2018
Q2 		$999K Buy
+9,090
New +$947K 0.19% 121

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Girard Partners's DGX Position: Q2 2024 in Review

Girard Partners reduced its Quest Diagnostics (DGX) stake by 34% in Q2 2024, selling an estimated $119K and leaving 1,662 shares worth $228K. The position accounts for 0.02% of the portfolio, ranked #243.

Girard Partners first reported a position in DGX in Q2 2018 and has held it in 25 quarters since. The position peaked at $6.97M in Q4 2021. 837 funds tracked by Wall St. Rank hold DGX as of Q2 2024.

  • Girard Partners held 1,662 shares of Quest Diagnostics worth $228K as of Q2 2024.
  • Girard Partners sold 870 Quest Diagnostics shares in Q2 2024, an estimated $119K.
  • Quest Diagnostics made up 0.02% of Girard Partners's portfolio in Q2 2024, its #243 holding.
  • Girard Partners first reported a position in Quest Diagnostics in Q2 2018 and has held it in 25 quarters since.
  • Girard Partners's Quest Diagnostics position peaked at $6.97M in Q4 2021.
  • 837 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2024.

Based on Girard Partners's 13F filing for Q2 2024, filed 12 Aug 2024.